Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 5, 1997, Pages 1031-1036

  Granfors, Torvald ^a   Damber, Jan Erik ^a   Bergh, Anders ^a   Landström, Maréne ^a   Löfroth, Per Olov ^a   Widmark, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Adjuvant hormonal therapy; Androgen deprivation; Castration; Dunning R3327 rat prostatic adenocarcinoma; Neoadjuvant hormonal therapy; Prostate cancer; Radiotherapy

Indexed keywords

ANDROGEN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CASTRATION; CONTROLLED STUDY; IRRADIATION; LINEAR ACCELERATOR; MALE; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RAT; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; MALE; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RATS;

EID: 0030707832     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00559-2     Document Type: Article

References (29)

1. Aalto, Y.; Forsgren, S.; Kjörell, U.; Franzén, L.; Gustafsson, H.; Henriksson, R. Time-and dose-related changes in the expression of substance P in salivary glands in response to fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 33: 297-305; 1995.
2. Camuzzi, F.; Block, N. L.; Stover, B.; Gottlieb, C.; Charyulu, K.; Politano, V. A. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327). Urology 15:443-447; 1980.
3. Culig, Z.; Hobisch, A.; Cronauer, M. V.; Radmayr, C.; Hittmair, A.; Zhang, J.; Thurnher, M.; Bartsch, G.; Klocker, H. Regulation of prostatic growth and function by peptide growth factors. Prostate 28:392-405; 1996.
4. Denekamp, J. Vascular endothelium as the vulnerable element in tumors. Acta. Radiol. Oncol. 23:217-225; 1984.
5. Eklöv, S.; Nilsson, S.; Larson, A.; Björk, P.; Hartley-Asp, B. Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo. Prostate 20:43-50; 1992.
6. Fuks, Z.; Persaud, R. S.; Alfieri, A.; McLoughlin, M.; Ehleiter, D.; Schwartz, J. L.; Seddon, A. P.; Cordon-Cardo, C.; Haimovitz-Friedman, A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54:2582-2590; 1994.
7. Green, N.; Bodner, H.; Broth, E.; Chiang, C.; Garrett, J.; Goldstein, A.; Goldberg, H.; Gualtieri, V.; Gray, R.; Jaffe, J.; Kaplan, R.; Polse, S.; Ross, S.; Skaist, L.; Treible, D.; Vatz, A.; Wallack, H. Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 10:971-976; 1984.
8. Hanks, G. E. Conformal radiation in prostate cancer: Reduced morbidity with hope of increased local control. Int. J. Radiat. Oncol. Biol. Phys. 25:377-378; 1993.
9. Hanks, G. E.; Lee, W. R.; Schultheiss, T. E. Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. J. Urol. 154:456-459; 1995.
10. Hanks, G. E. Optimizing the radiation treatment and outcome of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 11:1235-1245; 1985.
11. Isaacs, J. T.; Coffey, D. S. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res. 41:5070-5075; 1981.
12. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. The significance of post-irradiation prostate biopsy with long-term follow-up. Int. J. Radiat. Oncol. Biol. Phys. 24:409-414; 1992.
13. Kuettel, M. R.; Thraves, P. J.; Jung, M.; Varghese, S. P.; Prasad, S. C.; Rhim, J. S.; Dritschilo, A. Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res. 56:5-10; 1996.
14. Landström, M.; Bergh, A.; Tomic, R.; Damber, J.-E. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate 17:57-68; 1990.
15. Leibel, S. A.; Zelefsky, M. J.; Kutcher, G. J.; Burman, C. M.; Mohan, R.; Mageras, G. S.; Ling, C. C.; Fuks, Z. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin. Oncol. 21:580-597; 1994.
16. Mador, D.; Ritchie, B.; Meeker, B.; Moore, R.; Elliot, F. G.; McPhee, M. S.; Chapman, J. D.; Lakey, W. H. Response of the Dunning R3327H prostatic adenocarcinoma to radiation and various chemotherapeutic drugs. Cancer Treat. Rep. 66: 1837-1843; 1982.
17. Pilepich, M. V.; Sause, W. T.; Shipley, W. U.; Krall, J. M.; Lawton, C. A.; Grignon, D.; Al-Sarraf, M.; Abrams, R. A.; Caplan, R.; John, M. J.; Rotman, M.; Cox, J. D.; Doggett, R. L. S.; Rubin, P. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the radiation therapy oncology group. Urology 45:616-623; 1995.
18. Shearer, R. J.; Davies, J. H.; Gelister, J. S. K.; Dearnaley, D. P. Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br. J. Urol. 69:521-524; 1992.
19. Sklar, G. N.; Eddy, H. A.; Jacobs, S. C.; Kyprianou, N. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: The role of apoptosis. J. Urol. 150:1526-1532; 1993.
20. Smit, W. G. J. M.; Helle, P. A.; van Putten, W. L. J.; Wijnmaalen, A. J.; Seldenrath, J. J.; van der Werf-Messing, B. H. P. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int. J. Radiat. Oncol. Biol. Phys. 18:23-29; 1990.
21. Smolev, J. K.; Heston, W. D. W.; Scott, W. W.; Coffey, D. S. Characterization of the Dunning R3327H prostatic adenocarcinoma: An appropriate animal model for prostatic cancer. Cancer Treat. Rep. 61:273-287; 1977.
22. Stamey, T. A.; Ferrari, M. K.; Schmid, H.-P. The value of serial prostate specific antigen determinations 5 years after radiotherapy: Steeply increasing values characterize 80% of patients. J. Urol. 150:1856-1859; 1993.
23. Stromberg, J.; Martinez, A.; Benson, R.; Garton, G.; Diokno, A.; Gonzalez, J.; Zincke, H.; Schray, M.; Edmundson, G.; Brabbins, D. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation. Int. J. Radiat. Oncol. Biol. Phys. 28:67-75; 1994.
24. Thorndyke, C.; Meeker, B. E.; Thomas, G.; Lakey, W. H.; McPhee, M. S.; Chapman, J. D. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas. J. Urol. 134:191-198; 1985.
25. Vaupel, P.; Frinak, S.; O'Hara, M. Direct measurement of reoxygenation in malignant mammary tumors after a single large dose of irradiation. Adv. Exp. Med. Biol. 180:773-782; 1984.
26. Westin, P.; Stattin, P.; Damber, J.-E.; Bergh, A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am. J. Pathol. 146:1368-1375; 1995.
27. Widmark, A.; Damber, J.-E., Bergh, A.; Henriksson, R. Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma. Prostate 24:79-83; 1994.
28. Zelefsky, M. J.; Leibel, S. A.; Burman, C. M.; Kutcher, G. J.; Harrison, A.; Happersett, L.; Fuks, Z. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 29:755-761; 1994.
29. Zietman, A. L.; Nakfoor, B. M.; Prince, E. A.; Gerweck, L. E. The effect of androgen deprivation and radiation therapy on an androgen-sensitive murine tumor: An in vitro and in vivo study. Cancer J. Sci. Am. 3:31-36; 1997.